Complement plays a role in the generation of antibody responses and immunological memory [11, 12] . There is evidence from studies in mice depleted of complement using cobra venom factor [13] and in C4, C2 and C3 deficient guinea pigs [12] that C3 activation via the classical pathway is an important step in generating a normal humoral immune response, particularly to low doses of T cell-dependent antigens. Early components of the classical pathway of complement play a role in the processing and removal of immune complexes from the circulation and tissues. In humans with homozygous deficiency of one of the early components of classical complement pathway, the excess formation and defective clearance of immune complexes may predispose to the development of glomerulonephritis and autoimmune disease including especially SLE [14, 15] . IgA nephropathy has been described in patients and families with partial deficiency of regulatory factors properdin (P) or H and in a patient with homozygous deficiency of C3 [16] [17] [18] .
In this report we describe a Turkish family in which two siblings had homozygous Clq deficiency associated with SLE and IgA nephropathy. We examined the response of the patients and other family members to immunization with hepatitis B vaccine. We identified the molecular defect causing the Clq deficiency in this family and screened 92 genomic DNA samples from patients with SLE for this particular mutation, using the polymerase chain reaction (PCR) and restriction enzyme digestion.
Methods
Complement assays CH5O and AP5O. Classical pathway hemolytic complement activity was measured by plate assay, using antibody-sensitized sheep erythrocytes as previously described [19] . The alternative pathway hemolytic complement activity was measured by plate assay, using guinea pig erythrocytes in Mg-EGTA buffer as previously described [19] .
Clq. Plasma samples were initially screened by double immunodiffusion assay using sheep polyclonal anti-Clq (The Binding Site, Birmingham, UK). Antigenic Clq levels were measured by ELISA as previously described [20] . Other component assays. Cir, Cis, C4, C2, and C3 levels were measured by single radial immunodiffusion or rocket immunoelectrophoresis in 1.2% CFD/agarose, using specific polyclonal antisera (The Binding Site).
Anti-C]q antibodies. Antibodies to Cilq were measured by a modification of the method described by Seigert and colleagues [201 as previously described [3] .
DNA samples from patients with C]q deficiency and SLE Samples of genomic DNA were prepared [21] from peripheral blood from family members: the two patients, both parents and two unaffected siblings. In order to screen for the mutation detected in the family, genomic DNA samples were used from 85 Caucasoid and 7 Afro-Caribbean patients fulfilling the 1982 ARA classification criteria for SLE.
PCR oligonucleotides
Primers K3 and K4 were gift from Professor K.B.M. Reid, and other primers were synthesized by the Human Molecular Genetics Group (Cambridge, UK; Table 1 ).
Amplification of A-B and C-chain genes of Clq by PCR and sequence analysis
We amplified the complete A-, B-and C-chain genes of Clq from genomic DNA samples by polymerase chain reaction (PCR). We used primers C1QA15' and C1QA23' to amplify the A-chain, K3 and K4 to amplify the B-chain and C1QC15' and C1QC23' to amplify the C-chain ( The PCR products were quantified on a 0.8% agarose gel in IxTBE (90 mt Tris-HC1, 90 m boric acid, 2.5 mvt Na2EDTA, pH 8.3). PCR products were purified using the Wizard DNA Clean-Up System (Promega, Madison, WI, USA). The purified products were used as template DNA for sequence analysis using the fmol DNA sequencing system according to manufacturer's instructions (Promega).
Restriction enzyme analysis of exon 2 of A-chain
We amplified a 260 bp fragment from exon 2 of the A-chain from genomic DNA samples of all six family members and a panel of 102 SLE patients by PCR (using the primers C1QA-REV' and CIQA23'; Table 1 ). PCR reactions (20 jsl final volume) were performed with 20 mtt Tris-HCI (pH 8.4), 50 ifiM KCI, 1.5 mM MgC12, 100 M of each dNTP, 150 ng of each primer, SOng genomic DNA and 1 unit of Taq DNA polymerase (Gibco BRL). The reaction conditions were 30 amplification cycles of 94 for 30 seconds, 58 for one minute and 72 for 45 seconds. The PCR products were digested at 37 for two hours in a 20 tl volume containing lxReact 6 buffer (Gibco BRL), 5 tl of PCR product, and 10 units PvuII (New England Biolabs, Beverly, MA, USA). The fragments were separated on a 3% metaphor agarose gel (Flowgen, Sittingbourne, Kent, UK) in lx TBE buffer by electrophoresis at 50 V for one hour. The mutation observed in this family causes the loss of a PvuII site such that the PCR product remains at 260 bp. Normal samples are digested, producing 160 bp and 100 bp fragments.
Case reports Case 1. A girl aged 3.5 years presented with a two year history of photosensitive skin and scalp eruptions, associated with fatigue and arthralgia. Except for an older sister (Case 2) who had similar skin lesions, the rest of the family members were healthy. The parents were not consanguineously related.
Physical examination revealed erythematous desquamative and hyperkeratotic skin and scalp lesions. There were monilial and aphthous lesions of her mouth and palate, and finger and toenail deformity secondary to moniliasis. The rest of the physical examination was normal. Urinalysis was normal.
Blood tests showed hemoglobin 9 g!dl with an MCV of 71.7 fi (normal 80 to 100 fi) and serum ferritin level of 84.8 nglml (normal > 100 ng/ml). Immunoglobulins, direct Coombs' test, anti-nuclear antibodies (ANA), anti-dsDNA, and anti-cardiolipin antibodies measured by ELISA and ANA were normal or negative.
Complement assays showed absent CH5O and no Clq was detectable by single radial immunodiffusion ( Table 2) . Following Assay results of other complement proteins in the patient and her relatives are presented in Table 2 .
Her rash persisted and at the age of 5.5 she developed peripheral edema, +4 proteinuria on stick testing and reduced serum albumin concentration of 25 g/liter during a febrile episode associated with a culture-negative bronchopneumonia. Her ANA and anti-dsDNA levels had risen to 335 arbitrary ELISA units (AEU) (N < 250 AEU) and 750 AEU (normal < 100 AEU), respectively. Her ANA (1101, 452, 362, and 335 AEU) and anti-dsDNA levels (385, 342, 126, and 100 AEU) remained high on four subsequent occasions during a four month period. She was treated with fresh frozen plasma, IVIG, and antibiotics; however, proteinuria and hypoalbuminemia persisted and a renal biopsy was performed.
The renal biopsy showed the typical picture of mesangioproliferative glomerulonephritis with slight mesangial enlargement and minimal mesangial hypercellularity. By electron microscopy a few osmiophilic deposits were found along the mesangial basement membrane and in subepithelial position ( Fig. 1 ). Immunohistology could not be performed since only glutaraldehyde-fixed material was available for investigation.
A course of prednisolone 2 mg/kg was given for four months and she responded well with resolution of proteinuria, a rise in her serum albumin level and decrease in her anti-dsDNA level to normal (5 AEU). Prednisolone was gradually reduced to 10 mg on alternate days. At the age of 7 autoimmune serological analysis was repeated at Hammersmith Hospital. ANA and anti-dsDNA were negative. Anti-Ro antibodies were detected by counterimmunoelectrophoresis; rheumatoid factor assayed by latex agglutination was positive at a titer of 1:80, and IgG anticardiolipin antibodies (ACA), measured by ELISA, were strongly positive (IgG ACA = 68.7 AEU, normal <9.0 AEU); 1gM ACA were negative.
Case 2. The sister of case 1 presented at the age of 15 with photosensitive rash. She had a past history of two isolated episodes of macroscopic hematuria at age 8 that lasted for two weeks and resolved spontaneously.
Physical examination revealed erythematous desquamative skin lesions on her face and hands. The rest of the physical examination was normal. Urinalysis was normal.
Full blood count, serum urea, creatinine, total protein, albumin, sedimentation rate, CRP, immunoglobulins, ANA, anti-dsDNA, anti-cardiolipin antibodies were all within normal limits. When she was aged 17 an autoimmune serological analysis was repeated at Hammersmith Hospital. ANA, anti-dsDNA, anti-ENA and rheumatoid factor were all negative. IgG anticardiolipin antibodies were weakly positive (lgG ACA = 18.8 AEU, normal < 9.0 AEU); 1gM ACA were negative. Complement findings were identical to those of her sister ( Table 2 ).
During follow-up to the age of 17 she did not have any recurrence of macroscopic hematuria, however, on five occasions microscopic hematuria was detected and a renal biopsy was performed. Light microscopy showed similar findings to those seen in case 1 ( Fig. 2A) . Immunohistology showed mesangial deposits of IgA (Fig. 2B) , 1gM, C3 and C5b-9. By electron microscopy only very small osmiophilic deposits along the mesangial basement membrane were found (Fig. 3 ). The final diagnosis was of IgA nephropathy in a case of mesangioproliferative glomerulonephritis by light microscopy.
Results

Results of sequence analysis of A-B-C chain genes
The complete DNA sequence of A-, B-and C-chain genes of Clq, including the splice donor and splice acceptor sites was determined in genomic DNA derived from Case 1. A homozygous C to T transition at codon 186 in the A chain was identified. The same mutation was present in homozygous form in the other patient (case 2) and both of the parents and the two unaffected sibling were found to be heterozygous for this mutation by sequence analysis. Figure 4 shows the mutation in homozygous form in one of the affected siblings and in a heterozygous form in the mother in comparison with the sequence from a normal individual. This mutation causes a change from CAG to TAG at codon 186 that results in a premature stop codon, and also causes a loss of a recognition site for the restriction enzyme PvulI. No other coding abnormalities were found in any remaining Clq A-gene or the B-or C-chain genes. 
Results of restriction enzyme digestion analysis of the A chain PCR product
Digestion with PvuII of the PCR product from exon 2 of A chain confirmed that both patients are homozygous for the mutation. The 260 bp PCR products were resistant to digestion with PvuH, consistant with the loss of the PvuII site, due to the C to T transition at codon 186 (Fig. 5 ). Both parents and both unaffected sibs were confirmed as heterozygous for this mutation as there were three bands observed of 260 bp, 160 bp and 100 bp. This corresponds to the presence of one wild type and one mutant allele (Fig. 5 ).
This mutation is the same as that previously reported in a Slovakian patient with Clq deficiency [9, 22] . The finding of the same mutation responsible for cases of homozygous Clq deficiency in geographically-disperse patients suggests that the mutation might be of some antiquity. This prompted us to ask whether the same mutation might be found in other patients with SLE and conceivably could cause increased disease susceptibility when expressed in heterozygous form. We screened genomic DNA samples from 92 patients with SLE by PvuII digestion of the A-chain exon 2 PCR. The samples from the homozygous patient and heterozygous parents were used as positive controls. All of the 92 samples produced the 100 and 60 bp products, which indicates the presence of the recognition site for PvuII. It is therefore unlikely that the mutation identified in this family is a significant disease susceptibility gene in the population of lupus patients as a whole.
Immunization of the patients with hepatitis B vaccine
The two patients with Clq deficiency were vaccinated against hepatitis B with recombinant hepatitis B vaccine (Gen Hevac B, Pasteur Merieux, France). Both had no specific anti-HBS antibody before vaccination, and both had a normal lgG antibody S a PhIX Normal 174 Negative PhiX 174 1111 / Fig. 4 . DNA sequence of a normal individual, mother of case 1, and case I using sequencing oligonucleotide CJQA23'. The PCR product of the complete A-chain gene was used as template DNA. The gel was electrophoresed for 2.5 hours at 1.1 kV. The autoradiogram was exposed for 24 hours. Case 1 shows a C to T nucleotide change marked by an asterisk, resulting in a premature stop codon, TAG. The mother is a CIT heterozygote at this position. Fig. 5 . Digestion of PCR product from exon 2 of the A-chain with restriction enzyme PvuII. The family tree is shown at the top, with the affected status displayed. The PCR fragments were separated on a 3% Metaphor agarose gel in I >< TBE, electrophoresed at 40 V for 90 minutes and stained with ethidium bromide. DNA size standards are 250 ng PhiX 174 DNA digested with HaeIII. The lanes contain digested PCR product from a normal individual, father, case 2, two unaffected siblings, case 1, mother and a negative control for the PCR reaction. The uncut product is 260 bp and the two fragments produced by digestion are 160 and 100 bp. The parents and unaffected sibs are confirmed as heterozygotes for the loss of the PvuII site and the two patients are homozygous for the loss of the PvuII site.
response with levels of 128300 and 131690 lU/liter (normal > 1250 lU/liter) four weeks after the last of the three injections.
Discussion
There are three points for discussion in relation to this new family with homozygous Clq deficiency: (i) the finding of a mutation identical to that previously reported in a Slovakian family; (ii) the presence of IgA nephropathy in case 2; and (iii) the normal response to hepatitis B vaccination. Clq deficiency presents in two different forms, absent Cl q protein or presence of a dysfunctional molecule. The molecular basis of both forms of deficiency has been characterized in six cases [4, [8] [9] [10] . The first molecular lesion, reported by McAdam, Goundis and Reid [8] , was a homozygous G to A mutation at residue 150 in the B-chain resulting in a premature stop codon.
The second report was of a point mutation at codon G1n186 (CAG to TAG) in the globular region of the A chain, which also caused a premature stop codon [9, 22] . The other four mutations were found in C chain. One patient had a homozygous deletion of a C nucleotide at position 43 of the C chain, resulting in a frame shift with premature stop codon in frame at position 108 [4] , the other had a homozygous C to T mutation at position 41 of the C-chain resulting in a premature stop codon [41 Two further cases presented with dysfunctional Clq deficiency from two racially distinct groups but showed the same homozygous point mutation (G to A) at position 6 of the C chain [4, 10] The patients presented here have the same mutation to that previously reported in a Slovakian family [9, 22] . The molecular basis of Clq deficiency has now been determined in patients from seven families. It is remarkable that among this small number of families two mutations have each been found in two families. The two families sharing each mutation were widely separated, in one case geographically (Central Turkey and Slovakia), and in the other geographically and ethnically (Punjabi from India and Sudeten-German). There are two explanations for these findings:
(i) that the mutations are ancient and therefore widely distributed; or (ii) that the same mutations have arisen spontaneously on two occasions. We performed a limited test of the first hypothesis by screening a population of predominantly Western European Caucasoid patients with SLE to see if further examples of either of these mutations could be identified, and to test the hypothesis that heterozygous deficiency of Clq might increase disease susceptibility to the development of SLE. We did not find further examples of either mutation [4, and the present report]. We are currently collecting samples from other Turkish patients with SLE to see how widespread the mutation is in the local population. In this context it is interesting to note that the parents of the two patients described in this report were not known to be consanguineously related, and that other Turkish patients with the Clq deficiency have been described [1, reviewed in 3].
There have been a number of reports of associations of complement deficiency with the development of IgA nephropathy.
A 23-year-old Japanese male with a homozygous C3 deficiency presented with a three year history of proteinuria and microhematuria, and a renal biopsy showing marked deposition of IgA in glomerular mesangium [18] . IgA nephropathy has also been described in patients with less well characterized, familial abnormalities in expression of complement Factor H and properdin [16, 17] . Three patients have been described with hereditary angioedema from a single family who all developed IgA nephropathy [241. Hereditary angioedema is associated with severe and persistent hypocomplementemia of C4 and C2 secondary to the failure of regulation of activated Cis in the presence of heterozygous Cl inhibitor deficiency. Hereditary angioedema is also associated with the development of SLE [25] . The etiology of IgA nephropathy is unknown, however, these rare associations of IgA nephropathy with hereditary and acquired complement deficiencies implies that a normally functioning complement system may provide some protection against the development of this disease.
There is a substantial body of evidence that complement plays an important role in the antibody response [reviewed in 11, 12, [26] [27] [28] . In animal models it was found that there was a defect in antibody responses that was a function of the immunizing dose of antigen. By using high doses of bacteriophage 1X174 as an immunogen, the titers of the primary and secondary antibody responses in complement-deficient guinea pigs approached normal, but the normal switch from 1gM to IgG did not occur as part of the secondary response and the IgG anti-X174 antibody response was markedly impaired [27, 281. Experimental studies of immunization of complement deficient patients are few and far between. The South African patient with C3 deficiency studied by Alper and colleagues [29] showed a normal anamnestic response to diphtheria toxoid and a normal primary antibody response to the polyribose phosphate antigen of H. influenzae in terms of quantitative antibody response. Two C3 deficient subjects were immunized with 1X174 and these patients demonstrated normal titers of antibody following both primary and secondary immunizations, but a failure to switch the antibody response from 1gM to IgG [30] . A further patient with C3 deficiency was given a primary immunization with hemocyanin and was reported to show a reduced response [31] . This same subject showed a fourfold increase in titer in response to secondary immunization with diphtheria, tetanus, and pertussis vaccine, which was considered normal [31] . A further patient showed a normal anamnestic response to typhoid immunization [32] .
Our two patients with Clq deficiency were vaccinated against hepatitis B with recombinant hepatitis B vaccine. Both had no specific anti-HBS antibody before vaccination, and both had a normal IgG antibody response four weeks after the last of the three injections. Thus, in these two Clq deficient patients, the total lack of classical pathway function did not impair a normal immune response towards HBSAg vaccine.
This family takes the total number of patients with homozygous Clq deficiency reported to 34. All but one of the patients had SLE or an SLE-like illness. Clq deficiency, although very rare, is a powerful disease susceptibility gene for the development of SLE.
